Complete Filing Data
Franklin BSP Capital Corp reported Stockholders Equity of $1.84 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Franklin BSP Capital Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Other General And Administrative Expense | $7.1M | $6.8M | $2.1M | $1.2M | $979.0K | $0.00 |
| Net Income Loss Available To Common Stockholders Including Impact From Temporary Equity | $98.0M | $82.0M | $37.1M | $21.8M | $6.9M | -$414.0K |
| Net Income Loss | $104.3M | $89.3M | $44.8M | $23.2M | $6.9M | -$414.0K |
| Income Taxes Paid Net | $1.1M | $4.3M | $325.0K | $476.0K | $99.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other General And Administrative Expense | $1.6M | $2.4M | $1.8M | $1.8M | $1.4M | $1.7M | $413.0K | $456.0K | $456.0K | $306.0K | $347.0K | $283.0K |
| Net Income Loss Available To Common Stockholders Including Impact From Temporary Equity | $22.8M | $24.5M | $23.2M | $28.9M | $31.2M | $24.0M | $12.8M | $9.3M | $9.6M | $6.5M | $1.8M | $4.7M |
| Net Income Loss | $24.3M | $26.2M | $24.9M | $30.5M | $32.9M | $26.2M | $15.0M | $11.5M | $10.6M | $7.0M | $2.1M | $4.8M |
| Income Taxes Paid Net | $720.0K | $4.1M | $123.0K | $273.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $1.84B | $1.91B | $388.1M | $372.4M | $236.0M | -$412.0K |
| Temporary Equity Dividends Adjustment | $6.3M | $7.3M | $7.6M | $1.4M | $0.00 | $0.00 |
| Temporary Equity Accretion To Redemption Value Adjustment | $18.0K | $18.0K | $17.0K | $3.0K | $0.00 | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $120.7M | $130.8M | $55.2M | $26.2M | $12.9M | $2.0K |
| Temporary Equity Carrying Amount Attributable To Parent | $77.4M | $77.4M | $77.4M | $36.1M | $5.0M | $0.00 |
| Debt And Equity Securities Realized Gain Loss | -$32.9M | -$22.8M | $496.0K | $467.0K | $618.0K | $0.00 |
| Cash And Cash Equivalents At Carrying Value | $100.6M | $119.1M | $48.5M | $26.2M | $12.9M | |
| Stockholders Equity Period Increase Decrease | -$70.3M | $1.52B | $15.7M | $136.4M | $236.4M | -$412.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$10.1M | $75.5M | $29.0M | $13.4M | $12.9M | |
| Accretion Amortization Of Discounts And Premiums Investments | $9.6M | $21.5M | $1.8M | $1.2M | $356.0K | |
| Restricted Cash | $20.1M | $11.7M | $6.7M | $0.00 | $0.00 | |
| Retained Earnings Accumulated Deficit | -$691.0M | -$607.6M | -$12.2M | -$3.2M | $4.8M | |
| Receivable Investment Sale | $2.4M | $5.1M | $422.0K | $713.0K | $166.0K | |
| Prepaid Expense And Other Assets | $4.4M | $6.9M | $3.4M | $72.0K | $74.0K | |
| Other Liabilities | $1.3M | $1.5M | $551.0K | $2.3M | $3.0M | |
| Management Fee Payable | $15.4M | $15.2M | $1.1M | $1.0M | $526.0K | |
| Long Term Debt | $2.25B | $2.05B | $319.9M | $379.6M | $237.5M | |
| Liabilities And Stockholders Equity | $4.25B | $4.17B | $831.7M | $816.2M | $541.3M | |
| Liabilities | $2.33B | $2.18B | $366.2M | $407.7M | $300.3M | |
| Investment Owned Percent Of Net Assets | $2.21 | $2.08 | $1.95 | $2.10 | $2.19 | |
| Investment Company Percent Of Net Assets Qualifying | $0.92 | $0.89 | $1.00 | $0.98 | $0.95 | |
| Interest Payable Current And Noncurrent | $28.3M | $18.2M | $6.9M | $1.4M | $474.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.84B | $1.85B | $1.90B | $1.95B | $1.95B | $2.00B | $390.6M | $384.0M | $382.5M | $351.3M | $260.2M | $237.7M |
| Temporary Equity Dividends Adjustment | $1.5M | $1.7M | $1.7M | $1.7M | $1.7M | $2.2M | $2.2M | $2.2M | $1.0M | $508.0K | $253.0K | $97.0K |
| Temporary Equity Accretion To Redemption Value Adjustment | $5.0K | $4.0K | $5.0K | $5.0K | $4.0K | $5.0K | $5.0K | $4.0K | $3.0K | $1.0K | $1.0K | -$1.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $125.6M | $121.4M | $205.5M | $153.7M | $82.4M | $114.2M | $70.0M | $47.7M | $16.4M | $27.4M | $13.7M | $9.5M |
| Temporary Equity Carrying Amount Attributable To Parent | $77.4M | $77.4M | $77.4M | $77.4M | $77.4M | $77.4M | $77.4M | $77.4M | $77.4M | $20.0M | $10.0M | $5.0M |
| Debt And Equity Securities Realized Gain Loss | $970.0K | $3.5M | -$22.7M | $1.3M | -$211.0K | $31.0K | -$161.0K | $197.0K | $54.0K | $12.0K | ||
| Cash And Cash Equivalents At Carrying Value | $108.6M | $105.3M | $189.9M | $135.4M | $64.6M | $96.4M | $70.0M | $47.7M | $16.4M | |||
| Stockholders Equity Period Increase Decrease | -$9.2M | -$11.5M | -$7.5M | $1.61B | $10.1M | $1.7M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $74.7M | $58.9M | -$9.8M | -$3.3M | ||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $3.6M | $12.0M | $552.0K | $328.0K | ||||||||
| Restricted Cash | $17.0M | $16.2M | $15.5M | $18.3M | $17.8M | $17.7M | $0.00 | $0.00 | $0.00 | |||
| Retained Earnings Accumulated Deficit | -$665.8M | -$649.7M | -$629.2M | -$28.6M | -$13.2M | $597.0K | -$3.9M | -$5.8M | -$4.1M | |||
| Receivable Investment Sale | $46.6M | $31.3M | $2.3M | $8.6M | $13.1M | $7.0M | $10.5M | $1.6M | $1.4M | |||
| Prepaid Expense And Other Assets | $6.2M | $6.5M | $5.9M | $6.0M | $6.2M | $11.1M | $1.3M | $327.0K | $74.0K | |||
| Other Liabilities | $780.0K | $843.0K | $928.0K | $1.1M | $742.0K | $581.0K | $2.1M | $2.2M | $2.2M | |||
| Management Fee Payable | $15.5M | $15.3M | $15.0M | $14.6M | $13.9M | $10.6M | $1.1M | $1.0M | $1.0M | |||
| Long Term Debt | $2.30B | $2.28B | $2.12B | $1.90B | $1.58B | $1.48B | $342.0M | $341.8M | $309.5M | |||
| Liabilities And Stockholders Equity | $4.31B | $4.29B | $4.18B | $4.04B | $3.72B | $3.66B | $858.6M | $853.3M | $813.0M | |||
| Liabilities | $2.39B | $2.36B | $2.20B | $2.01B | $1.68B | $1.59B | $390.7M | $391.9M | $353.1M | |||
| Investment Owned Percent Of Net Assets | $2.21 | $2.20 | $2.06 | $1.95 | $1.82 | $1.74 | $1.94 | $2.07 | $2.06 | |||
| Investment Company Percent Of Net Assets Qualifying | $0.91 | $0.91 | $0.91 | $0.89 | $0.89 | $0.90 | $1.00 | $0.97 | $0.98 | |||
| Interest Payable Current And Noncurrent | $27.1M | $23.2M | $26.3M | $33.2M | $25.2M | $28.2M | $6.3M | $2.0M | $1.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Proceeds From Disposition Of Investment Operating Activity | $965.8M | $651.2M | $101.7M | $58.6M | $8.7M |
| Payments Of Dividends Preferred Stock And Preference Stock | $6.3M | $7.3M | $7.6M | $1.4M | $0.00 |
| Payments Of Dividends Common Stock | $132.1M | $111.9M | $31.2M | $19.2M | $1.5M |
| Payments For Purchase Of Investment Operating Activity | $1.09B | $1.10B | $77.0M | $327.9M | $522.8M |
| Net Cash Provided By Used In Operating Activities | $6.1M | -$210.3M | $66.1M | -$259.5M | -$491.4M |
| Net Cash Provided By Used In Financing Activities | -$16.2M | $285.8M | -$37.1M | $272.9M | $504.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.5M | -$2.6M | $3.3M | -$2.0K | $74.0K |
| Increase Decrease In Other Operating Liabilities | -$211.0K | $945.0K | -$1.7M | -$708.0K | $1.9M |
| Increase Decrease In Management Fee Payable | $257.0K | $11.4M | $59.0K | $481.0K | $526.0K |
| Increase Decrease In Interest Payable Net | $10.0M | $3.3M | $5.5M | $933.0K | $474.0K |
| Increase Decrease In Directors Fees Payable | $0.00 | -$410.0K | $158.0K | $17.0K | $0.00 |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $3.8M | -$3.3M | $1.6M | $322.0K | $2.3M |
| Proceeds From Issuance Of Common Stock | $0.00 | $900.0K | $9.9M | $142.0M | $222.6M |
| Payments Of Financing Costs | $9.3M | $7.6M | $2.3M | $1.1M | $3.0M |
| Increase Decrease In Receivable For Investment Sold | -$2.7M | $3.2M | -$291.0K | $547.0K | $166.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Disposition Of Investment Operating Activity | $323.9M | $151.3M | $13.4M | $4.4M |
| Payments Of Dividends Preferred Stock And Preference Stock | $1.7M | $2.2M | $1.0M | $0.00 |
| Payments Of Dividends Common Stock | $34.7M | $7.9M | $7.6M | $3.1M |
| Payments For Purchase Of Investment Operating Activity | $282.5M | $67.1M | $18.6M | $34.3M |
| Net Cash Provided By Used In Operating Activities | $73.8M | $196.0M | $5.0M | -$39.1M |
| Net Cash Provided By Used In Financing Activities | $923.0K | -$137.1M | -$14.8M | $35.7M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.0M | $1.7M | $2.0K | -$11.0K |
| Increase Decrease In Other Operating Liabilities | -$574.0K | $27.0K | -$33.0K | -$1.5M |
| Increase Decrease In Management Fee Payable | -$177.0K | $6.8M | $0.00 | $154.0K |
| Increase Decrease In Interest Payable Net | $8.0M | $13.3M | $454.0K | $103.0K |
| Increase Decrease In Directors Fees Payable | $15.0K | -$393.0K | $11.0K | $35.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$1.2M | -$1.5M | $323.0K | -$538.0K |
| Proceeds From Issuance Of Common Stock | $0.00 | $8.3M | $8.4M | |
| Payments Of Financing Costs | $3.6M | $0.00 | $0.00 | $371.0K |
| Increase Decrease In Receivable For Investment Sold | -$2.8M | $5.1M | $700.0K | $407.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $13.58 | $14.10 | $14.88 | $15.13 | $15.46 | $15.00 |
| Temporary Equity Shares Outstanding | 77.5K | 77.5K | 77.5K | 36.1K | 5.0K | 0.00 |
| Investment Company Investment Income Loss Per Share | $1.21 | $1.47 | $2.11 | $1.68 | $0.78 | $-4,133.15 |
| Weighted Average Number Of Shares Outstanding Basic | 135.0M | 128.1M | 25.5M | 18.7M | 5.3M | 100.00 |
| Weighted Average Number Of Diluted Shares Outstanding | 135.0M | 128.1M | 25.5M | 18.7M | 5.3M | 100.00 |
| Investment Company Investment Income Loss From Operations Per Share | $0.77 | $0.70 | $1.77 | $1.24 | $1.30 | |
| Earnings Per Share Diluted | $0.73 | $0.64 | $1.41 | $1.12 | $1.30 | $-4,133.15 |
| Earnings Per Share Basic | $0.73 | $0.64 | $1.41 | $1.12 | $1.30 | $-4,133.15 |
| Common Stock Shares Outstanding | 135.5M | 135.5M | 26.1M | 24.6M | 15.3M | 100.00 |
| Temporary Equity Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $13.67 | $13.79 | $13.94 | $14.44 | $14.56 | $14.66 | $15.10 | $15.03 | $15.10 | $15.15 | $15.19 | $15.47 |
| Temporary Equity Shares Outstanding | 77.5K | 77.5K | 77.5K | 77.5K | 77.5K | 77.5K | 77.5K | 77.5K | 77.5K | 20.0K | 10.0K | 5.0K |
| Investment Company Investment Income Loss Per Share | $0.30 | $0.29 | $0.33 | $0.33 | $0.36 | $0.49 | $0.55 | $0.54 | $0.49 | $0.44 | $0.37 | $0.36 |
| Weighted Average Number Of Shares Outstanding Basic | 134.5M | 135.1M | 135.6M | 134.6M | 135.1M | 101.2M | 25.7M | 25.5M | 24.6M | 19.5M | 16.0M | 15.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 134.5M | 135.1M | 135.6M | 134.6M | 135.1M | 101.2M | 25.7M | 25.5M | 24.6M | 19.5M | 16.0M | 15.3M |
| Investment Company Investment Income Loss From Operations Per Share | $0.18 | $0.19 | $0.18 | $0.23 | $0.24 | $0.26 | $0.58 | $0.45 | $0.43 | $0.38 | $0.12 | $0.32 |
| Earnings Per Share Diluted | $0.17 | $0.18 | $0.17 | $0.21 | $0.23 | $0.24 | $0.49 | $0.36 | $0.34 | $0.34 | $0.10 | $0.30 |
| Earnings Per Share Basic | $0.17 | $0.18 | $0.17 | $0.21 | $0.23 | $0.24 | $0.49 | $0.36 | $0.34 | $0.34 | $0.10 | $0.30 |
| Common Stock Shares Outstanding | 134.9M | 134.4M | 136.2M | 134.8M | 134.2M | 136.3M | 25.9M | 25.5M | 25.3M | 23.2M | 17.1M | 15.4M |
| Temporary Equity Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Dividend Reinvestment Plan | $35.7M | $33.1M | $12.4M | $8.1M | $790.0K | $0.00 |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction After Tax | -$26.7M | -$76.3M | -$7.8M | -$8.7M | $2.1M | $0.00 |
| Investment Income Operating After Expense And Tax | $163.9M | $188.4M | $53.6M | $31.5M | $4.1M | -$414.0K |
| Investment Company Dividend Distribution | $167.7M | $145.0M | $43.6M | $27.3M | $2.3M | $0.00 |
| Stock Issued During Period Value New Issues | $0.00 | $900.0K | $9.7M | $133.9M | $231.0M | $2.0K |
| Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $6.1M | $2.1M | $768.0K | $780.0K | $0.00 | $0.00 |
| Professional Fees | $7.4M | $7.5M | $2.1M | $1.7M | $1.3M | $117.0K |
| Other Interest And Dividend Income | $3.7M | $4.3M | $1.7M | $188.0K | $1.0K | $0.00 |
| Noninterest Expense Directors Fees | $1.0M | $1.1M | $1.0M | $573.0K | $386.0K | $0.00 |
| Net Investment Income | $167.2M | $189.4M | $53.9M | $32.1M | $4.2M | -$414.0K |
| Management Fee Expense | $61.1M | $54.1M | $4.2M | $3.4M | $1.1M | $0.00 |
| Investment Income Operating Tax Expense Benefit | $3.3M | $1.0M | $334.0K | $671.0K | $99.0K | $0.00 |
| Investment Income Investment Expense | $251.2M | $223.9M | $48.5M | $28.9M | $9.1M | $414.0K |
| Incentive Fee Expense Income Based | $33.0M | $36.0M | $7.7M | $4.7M | $711.0K | $0.00 |
| Gross Investment Income Operating | $418.5M | $413.3M | $94.7M | $56.7M | $12.2M | $0.00 |
| Administrative Fees Expense | $865.0K | $917.0K | $302.0K | $226.0K | $113.0K | $0.00 |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction After Tax | -$32.9M | -$22.8M | -$987.0K | $467.0K | $618.0K | |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$59.6M | -$99.1M | -$8.8M | -$8.3M | $2.7M | |
| Amortization Of Financing Costs | $3.0M | $1.3M | $1.0M | $1.2M | $647.0K | |
| Realized And Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $6.1M | $2.1M | $768.0K | $780.0K | $0.00 | $0.00 |
| Investment Company Increase Decrease From Share Transaction | -$551.0K | $1.59B | $22.1M | $141.9M | $231.8M | |
| Stock Repurchased During Period Value | $36.2M | $43.0M | $0.00 | $0.00 | ||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $251.2M | $223.9M | $40.8M | $24.6M | $8.0M | $414.0K |
| Investment Company Contractual Fee Waived | $0.00 | $0.00 | $7.7M | $4.3M | $1.1M | $0.00 |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating After Tax | -$20.2M | -$74.2M | -$7.0M | -$8.0M | $2.1M | |
| Interest Paid Net | $125.8M | $108.4M | $17.9M | $15.1M | $2.3M | |
| Investment Owned At Fair Value | $4.07B | $3.97B | $756.1M | $782.4M | $517.3M | |
| Investment Owned At Cost | $4.18B | $4.05B | $769.0M | $788.2M | $515.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Dividend Reinvestment Plan | $8.2M | $9.3M | $10.0M | $9.8M | $9.9M | $3.3M | $3.1M | $3.1M | $3.0M | $2.2M | $1.7M | $1.5M |
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction After Tax | -$16.8M | -$1.9M | -$23.5M | $8.8M | -$16.0M | -$24.8M | $1.1M | -$2.2M | -$1.3M | -$1.7M | -$3.9M | -$634.0K |
| Investment Income Operating After Expense And Tax | $40.1M | $39.6M | $44.9M | $44.4M | $48.7M | $49.7M | $14.1M | $13.6M | $12.1M | $8.6M | $5.9M | $5.5M |
| Investment Company Dividend Distribution | $39.0M | $44.9M | $44.7M | $44.3M | $45.0M | $11.2M | $11.0M | $10.9M | $10.6M | $7.7M | $6.0M | $4.6M |
| Stock Issued During Period Value New Issues | $0.00 | $0.00 | $900.0K | $0.00 | $1.6M | $8.1M | $90.0M | $25.0M | $0.00 | |||
| Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $1.1M | $1.7M | $2.0M | $638.0K | $738.0K | $291.0K | $6.0K | $0.00 | $515.0K | $171.0K | $0.00 | $0.00 |
| Professional Fees | $1.5M | $1.8M | $2.1M | $2.1M | $1.8M | $2.0M | $493.0K | $511.0K | $512.0K | $494.0K | $349.0K | $409.0K |
| Other Interest And Dividend Income | $923.0K | $1.0M | $1.0M | $1.1M | $970.0K | $1.1M | $732.0K | $313.0K | $101.0K | $66.0K | $9.0K | $1.0K |
| Noninterest Expense Directors Fees | $256.0K | $243.0K | $258.0K | $255.0K | $268.0K | $331.0K | $296.0K | $274.0K | $149.0K | $139.0K | $139.0K | $156.0K |
| Net Investment Income | $41.1M | $40.7M | $45.3M | $45.3M | $49.6M | $50.1M | $14.1M | $13.8M | $12.3M | $8.7M | $6.0M | $5.8M |
| Management Fee Expense | $15.5M | $15.2M | $15.0M | $14.6M | $13.8M | $10.6M | $1.1M | $1.0M | $1.0M | $919.0K | $774.0K | $680.0K |
| Investment Income Operating Tax Expense Benefit | $1.0M | $1.1M | $355.0K | $869.0K | $889.0K | $326.0K | $50.0K | $210.0K | $208.0K | $89.0K | $91.0K | $323.0K |
| Investment Income Investment Expense | $62.8M | $62.7M | $62.2M | $60.9M | $55.1M | $46.5M | $12.3M | $12.0M | $12.0M | $8.6M | $5.4M | $4.6M |
| Incentive Fee Expense Income Based | $8.1M | $7.9M | $9.0M | $8.8M | $9.4M | $8.7M | $2.1M | $2.0M | $1.8M | $1.3M | $889.0K | $818.0K |
| Gross Investment Income Operating | $103.9M | $103.4M | $107.5M | $106.2M | $104.6M | $96.6M | $24.3M | $23.8M | $22.4M | $15.9M | $10.9M | $9.6M |
| Administrative Fees Expense | $217.0K | $211.0K | $220.0K | $222.0K | $224.0K | $246.0K | $48.0K | $91.0K | $58.0K | $51.0K | $57.0K | $47.0K |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction After Tax | $987.0K | -$11.5M | $3.5M | -$22.7M | $250.0K | $1.3M | -$211.0K | $31.0K | -$161.0K | |||
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | -$15.8M | -$13.4M | -$20.1M | -$13.9M | -$15.8M | -$23.5M | $931.0K | -$2.2M | -$1.4M | -$1.5M | -$3.9M | -$622.0K |
| Amortization Of Financing Costs | $754.0K | $652.0K | $599.0K | $357.0K | $271.0K | $269.0K | $254.0K | $252.0K | $346.0K | $243.0K | ||
| Realized And Unrealized Gain Loss Investment And Derivative Operating Tax Expense Benefit | $1.1M | $2.0M | $638.0K | $291.0K | $515.0K | $0.00 | ||||||
| Investment Company Increase Decrease From Share Transaction | $7.0M | $10.0M | $8.0M | $1.60B | $11.1M | $1.5M | ||||||
| Stock Repurchased During Period Value | $1.2M | $34.9M | $1.8M | $41.2M | ||||||||
| Investment Company Expense After Reduction Of Fee Waiver And Reimbursement | $60.9M | $55.1M | $46.5M | $10.2M | $10.0M | $10.2M | $7.3M | $4.9M | $3.8M | |||
| Investment Company Contractual Fee Waived | $0.00 | $0.00 | $0.00 | $2.1M | $2.0M | $1.8M | $1.3M | $573.0K | $725.0K | |||
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating After Tax | -$15.6M | -$21.2M | $9.4M | -$24.5M | -$746.0K | -$634.0K | ||||||
| Interest Paid Net | $24.6M | $9.2M | $7.1M | $1.9M | ||||||||
| Investment Owned At Fair Value | $4.08B | $4.08B | $3.91B | $3.81B | $3.56B | $3.48B | $759.1M | $795.6M | $787.6M | |||
| Investment Owned At Cost | $4.21B | $4.19B | $4.02B | $3.85B | $3.61B | $3.51B | $766.7M | $804.4M | $794.2M |
Most recent annual filing with the SEC: March 16, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.